Feb 22 (Reuters) - Novavax (NVAX.O), opens new tab has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines by the end of 2028, settling a dispute over ...

Novavax (NASDAQ:NVAX) has agreed to pay international vaccine group Gavi at least $475M in cash or vaccines by the end of 2028 to settle a dispute related to the 2021 advance purchase agreement ...

After a contentious dispute, Novavax has agreed to refund up to $475 ... disconcerting episode involving several vaccine makers and Gavi, the Vaccine Alliance, a public-private partnership that ...

Vaccine developer Novavax is seeing its stock skyrocket after resolving a dispute with the global nonprofit vaccine alliance Gavi.In an agreement, Novavax has refunded a large portion of Gavi's ...

Gavi, an alliance that co-finances vaccine purchases with low-income countries, paid Novavax $700 million over 2021 and 2022 for up to 350 million doses of its COVID va Novavax settles dispute ...

Novavax's revenue has seen a significant decline over the last twelve months as of Q3 2023, with a decrease of 43.15%. This trend is further highlighted by a quarterly revenue growth figure for Q3 ...

Feb 22 (Reuters) - Novavax said on Thursday it has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines by the end of 2028, settling a dispute over canceled ...

Novavax settles COVID-19 vaccine dispute with Gavi Alliance ...

GAITHERSBURG, Md. - Novavax , Inc. (NASDAQ:NVAX) has concluded a settlement with Gavi, the Vaccine Alliance, resolving the arbitration stemming from the 2021 Advance Purchase Agreement for Novavax's ...